CME Group Inc.

NasdaqGS:CME Voorraadrapport

Marktkapitalisatie: US$80.5b

CME Group Beheer

Beheer criteriumcontroles 3/4

De CEO CME Group is Terry Duffy, benoemd in Nov2016, heeft een ambtstermijn van 29.83 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 23.47M, bestaande uit 8.5% salaris en 91.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.026% van de aandelen van het bedrijf, ter waarde $ 21.23M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8 jaar en 19.5 jaar.

Belangrijke informatie

Terry Duffy

Algemeen directeur

US$23.5m

Totale compensatie

Percentage CEO-salaris8.5%
Dienstverband CEO8yrs
Eigendom CEO0.03%
Management gemiddelde ambtstermijn8yrs
Gemiddelde ambtstermijn bestuur19.5yrs

Recente managementupdates

Recent updates

Trade On, Cash In: Why CME Group Is My Pick For Income And Growth

Oct 27

Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

Oct 23
Do CME Group's (NASDAQ:CME) Earnings Warrant Your Attention?

CME Group: An Attractive Business Relatively Out Of Favor

Oct 15

CME Group: An Interesting Option For Every Dividend Investor

Oct 08

CME Group: Poised To Benefit From Rate Cuts; Continues To Innovate

Sep 03

CME Group Has It All - Growth, Dividend Growth, And Value

Aug 26

Down But Not Out: Why CME Group Remains One Of My Favorite Dividend Stocks

Aug 01

CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

Jul 02
CME Group Inc.'s (NASDAQ:CME) Price Is Out Of Tune With Earnings

CME Group: FMX Market Entry Poses Real Risk

Jul 01

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Jun 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Looking For (Special) Dividends? CME Group Remains One Of My Best Ideas In Finance

May 25

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

May 21
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Gunning For CME's Golden Goose

May 01

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26
Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

Mar 27

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Mar 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

CME Group Is One Of My Favorite High-Yielding Stocks Today

Feb 29

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

Feb 20
CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

CME Group: Buying 'The House' Proves A Winning Strategy

Feb 14

CME Group: Uncertainty In The World Equals Higher Revenue Growth

Feb 04

Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Dec 27
Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

Nov 14
Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Apr 28
We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Analyse CEO-vergoeding

Hoe is Terry Duffy's beloning veranderd ten opzichte van CME Group's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

US$3b

Jun 30 2024n/an/a

US$3b

Mar 31 2024n/an/a

US$3b

Dec 31 2023US$23mUS$2m

US$3b

Sep 30 2023n/an/a

US$3b

Jun 30 2023n/an/a

US$3b

Mar 31 2023n/an/a

US$3b

Dec 31 2022US$23mUS$2m

US$3b

Sep 30 2022n/an/a

US$3b

Jun 30 2022n/an/a

US$3b

Mar 31 2022n/an/a

US$3b

Dec 31 2021US$23mUS$2m

US$3b

Sep 30 2021n/an/a

US$2b

Jun 30 2021n/an/a

US$2b

Mar 31 2021n/an/a

US$2b

Dec 31 2020US$16mUS$2m

US$2b

Sep 30 2020n/an/a

US$2b

Jun 30 2020n/an/a

US$2b

Mar 31 2020n/an/a

US$2b

Dec 31 2019US$12mUS$2m

US$2b

Sep 30 2019n/an/a

US$2b

Jun 30 2019n/an/a

US$2b

Mar 31 2019n/an/a

US$2b

Dec 31 2018US$13mUS$2m

US$2b

Sep 30 2018n/an/a

US$5b

Jun 30 2018n/an/a

US$4b

Mar 31 2018n/an/a

US$4b

Dec 31 2017US$12mUS$2m

US$4b

Compensatie versus markt: De totale vergoeding ($USD 23.47M ) Terry } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.87M ).

Compensatie versus inkomsten: De vergoeding van Terry is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Terry Duffy (66 yo)

8yrs

Tenure

US$23,468,000

Compensatie

Mr. Terrence A. Duffy, also known as Terry, has been Chief Executive Officer and Chairman at CME Group, the world’s leading derivatives marketplace since November 15, 2016. Mr. Duffy is the Chief Executive...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Terrence Duffy
Chairman & CEO8yrsUS$23.47m0.026%
$ 21.2m
Lynne Fitzpatrick
Chief Financial Officer1.6yrsUS$2.56m0.0047%
$ 3.8m
Julie Holzrichter
Senior MD & COO10.2yrsUS$3.42m0.011%
$ 9.0m
Sunil Cutinho
Chief Information Officer2.8yrsUS$3.40m0.0075%
$ 6.0m
Derek Sammann
Senior MD & Global Head of Commodities Markets15.1yrsUS$3.41m0.0097%
$ 7.8m
Michael Dennis
Global Head of Fixed Incomeless than a yearUS$265.08k0.0018%
$ 1.4m
Jack Tobin
MD & Chief Accounting Officer9.8yrsgeen gegevens0.0065%
$ 5.3m
John Peschier
Managing Director of Investor Relationsno datageen gegevensgeen gegevens
Jonathan Marcus
Senior MD & General Counsel2.1yrsgeen gegevens0.0021%
$ 1.7m
Anita Liskey
Senior Managing Director of Corporate Marketing & Communications17.8yrsgeen gegevensgeen gegevens
Hilda Piell
Senior MD & Chief Human Resources Officer17.3yrsgeen gegevens0.0086%
$ 6.9m
Kendal Vroman
Chief Transformation Officer4.8yrsgeen gegevens0.0060%
$ 4.9m

8.0yrs

Gemiddelde duur

56yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CME is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Terrence Duffy
Chairman & CEO29.8yrsUS$23.47m0.026%
$ 21.2m
Larry Gerdes
Independent Director17.3yrsUS$323.50k0.011%
$ 9.1m
Terry Savage
Independent Director21.6yrsUS$264.08k0.0050%
$ 4.1m
Daniel Glickman
Independent Director23.3yrsUS$273.02k0.0047%
$ 3.8m
Dennis Suskind
Lead Independent Director16.3yrsUS$339.66k0.0011%
$ 877.7k
Martin Gepsman
Independent Director30.8yrsUS$277.08k0.0071%
$ 5.7m
William Shepard
Independent Director27.8yrsUS$258.50k0.072%
$ 57.6m
Howard Siegel
Independent Director24.8yrsUS$301.08k0.022%
$ 17.6m
Charles Carey
Independent Director17.3yrsUS$311.08k0.0024%
$ 1.9m
Timothy Bitsberger
Independent Director16.5yrsUS$325.08k0.0029%
$ 2.4m
Daniel Kaye
Independent Director5.5yrsUS$301.08k0.0012%
$ 934.0k
Phyllis Lockett
Independent Director5.5yrsUS$306.08k0.0012%
$ 934.0k

19.5yrs

Gemiddelde duur

70.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CME zijn ervaren en ervaren (gemiddelde ambtstermijn van 19.5 jaar).